Trimitra Trans Persada Tbk. vs Diagnos Laboratorium Utama Tbk. — how do they compare? Trimitra Trans Persada Tbk. trades at Rp350 (market cap 1.2T, 27.3K 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 308B, 22.7K 24h volume). The key difference: Trimitra Trans Persada Tbk. is far larger — about 3.9× Diagnos Laboratorium Utama Tbk.'s market cap, and Trimitra Trans Persada Tbk. is more actively traded (27.3K versus 22.7K). Which is the better fit depends on your goals.
| BLOG | DGNS | |
|---|---|---|
Market Cap | 1.2T | 308B |
Volume | 27.3K | 22.7K |
Lot | 273 | 227 |
Turnover | 9.56M | 5.17M |
Average Price | 350.02 | 227.59 |
Value | 9.56M | 5.17M |
Indicative Equilibrium Price | 350 | 230 |
Indicative Equilibrium Volume | 77 | 110 |
Trailing returns across standard periods
Latest headlines on both assets
PT Trimitra Trans Persada Tbk (the Company) was established based on Notarial Deed No. 28 by notary Kamelina, S.H., notary in Jakarta dated October 26, 2009.
Read more on BLOG →PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →